Literature DB >> 28291526

Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.

Avinoam Ophir1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28291526     DOI： 10.1016/j.ajo.2016.11.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  3 in total

Review 1.  Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis.

Authors:  Qiongzhen Yuan; Yilin Liu; Hanyue Xu; Yunxia Gao; Ling Qin; Yueqin Gou; Mengying Tao; Ming Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-22       Impact factor: 3.535

2.  Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial.

Authors:  Farhad Fazel; Hossein Nikpour; Mohsen Pourazizi
Journal:  Biomed Res Int       Date:  2020-01-16       Impact factor: 3.411

3.  Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers.

Authors:  Birgit Weingessel; Kata Miháltz; Andreas Gleiss; Florian Sulzbacher; Christopher Schütze; Pia V Vécsei-Marlovits
Journal:  J Ophthalmol       Date:  2018-10-01       Impact factor: 1.909
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.